Prostate Cancer Cell Adhesion to Bone Marrow Endothelium: The Role of Prostate-Specific Antigen

Cancer Research

Volumn 64, Issue 6, 2004, Pages 2083-2089

  Romanov, Victor I ^a   Whyard, Terry ^b   Adler, Howard L ^b   Waltzer, Wayne C ^b   Zucker, Stanley ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COMPLEMENTARY DNA; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN;

AMINO ACID SEQUENCE; ANTIGEN EXPRESSION; ARTICLE; BACTERIOPHAGE T7; BONE MARROW; BONE METASTASIS; CANCER CELL; CELL ADHESION; CELL INTERACTION; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DNA LIBRARY; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; METASTASIS INHIBITION; PHAGE DISPLAY; PRIORITY JOURNAL; PROSTATE CANCER; SEQUENCE HOMOLOGY;

APOPTOSIS; BONE AND BONES; BONE MARROW CELLS; CELL ADHESION; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; HUMANS; MALE; NEOPLASM INVASIVENESS; PEPTIDE FRAGMENTS; PEPTIDE LIBRARY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTEIN BINDING; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED;

EID: 1542615076     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-3487     Document Type: Article

References (29)

1. Cher ML. Mechanisms governing bone metastasis in prostate cancer. Curr Opin Urol 2001;11:483-8.
2. Lehr JE, Pienta KJ. Preferential adhesion of prostate cancer cells to a human bone marrow endothelial cell line. J Natl Cancer Inst (Bethesda) 1998;90:118-23.
3. Cooper CR, McLean L, Mucci NR, Poncza P, Pienta KJ. Prostate cancer cell adhesion to quiescent endothelial cells is not mediated by β-1 integrin subunit. Anticancer Res 2000;20:4159-62.
4. Orr FW, Wang HH, Lafrenie RM, Scherbarth S, Nance DM. Interactions between cancer cells and the endothelium in metastasis. J Pathol 2000;190:310-29.
5. Glinsky VV, Glinsky GV, Rittenhouse-Olson K, et al. The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium. Cancer Res 2001;61:4851-7.
6. Glinsky VV, Glinsky GV, Glinskii OV, et al. Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium. Cancer Res 2003;63:3805-11.
7. Khaldoyanidi SK, Glinsky VV, Sikora L, et al. MDA-MB-435 human breast carcinoma cell homo- and heterotypic adhesion under flow conditions is mediated in part by Thomsen-Friedenreich antigen-galectin-3 interactions. J Biol Chem 2003;278:4127-34.
8. Glinskii OV, Turk JR, Pienta KJ, Huxley VH, Glinsky VV. Evidence of porcine and human endothelium activation by cancer-associated carbohydrates expressed on glycoproteins and tumour cells. J Physiol 2004;554:89-99.
9. Almeida-Porada G, Ascensao JL. Isolation, characterization, and biologic features of bone marrow endothelial cells. J Lab Clin Med 1996;128:399-407.
10. Petrenko VA, Smith GP, Gong X, Quinn T. A library of organic landscapes on filamentous phage. Protein Eng 1996;9:797-801.
11. Romanov VI, Durand DB, Petrenko VA. Phage display selection of peptides that affect prostate carcinoma cells attachment and invasion. Prostate 2001;47:239-51.
12. Barry MA, Dower WJ, Johnston SA. Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries. Nat Med 1996;2:299-305.
13. Romanov VI, Goligorsky MS. RGD-recognizing integrins mediate interactions of human prostate carcinoma cells with endothelial cells in vitro. Prostate 1999;39:108-18.
14. Weaver VM, Petersen OW, Wang F, et al. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 1997;137:231-45.
15. Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS, McCauley LK. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 2002;62:1832-7.
16. Wu TT, Sikes RA, Cui Q, et al. Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines. Int J Cancer 1998;77:887-94.
17. Zhau HE, Li CL, Chung LW. Establishment of human prostate carcinoma skeletal metastasis models. Cancer (Phila.) 2000;88:2995-3001.
18. Park CC, Bissell MJ, Barcellos-Hoff MH. The influence of the microenvironment on the malignant phenotype. Mol Med Today 2000;6:324-9.
19. Webber MM, Bello D, Kleinman HK, Hoffman MP. Acinar differentiation by non-malignant immortalized human prostatic epithelial cells and its loss by malignant cells. Carcinogenesis (Lond.) 1997;18:1225-31.
20. Zozulya S, Lioubin M, Hill RJ, Abram C, Gishizky ML. Mapping signal transduction pathways by phage display. Nat Biotechnol 1999;17:1193-8.
21. Danner S, Belasco JG. T7 phage display: A novel genetic selection system for cloning RNA-binding proteins from cDNA libraries. Proc Natl Acad Sci USA 2001;98:12954-9.
22. Cochrane D, Webster C, Masih G, McCafferty J. Identification of natural ligands for SH2 domains from a phage display cDNA library. J Mol Biol 2000;297:89-97.
23. Sche PP, McKenzie KM, White JD, Austin DJ. Display cloning: functional identification of natural product receptors using cDNA-phage display. Chem Biol 1999;707-16. Erratum in: Chem Biol 2001;8:399-400.
24. Sche PP, McKenzie KM, White JD, Austin DJ. Display cloning: functional identification of natural product receptors using cDNA-phage display. Chem Biol 1999;707-16. Erratum in: Chem Biol 2001;8:399-400.
25. Fadok VA, Brathon DL, Rose DM, Pearson A, Ezekkewiltz RAB, Henson PM. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature (Lond.) 2000;405:85-90.
26. Essler M, Ruoslahti E. Molecular specialization of breast vasculature: a breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculature. Proc Natl Acad Sci USA 2002;99:2252-7.
27. Sinha AA, Jamuar MP, Wilson MJ, Rozhin J Sloane BF. Plasma membrane association of cathepsin B in human prostate cancer: biochemical and immunogold electron microscopic analysis. Prostate 2001;49:172-84.
28. Denmeade SR, Litvinov I, Sokoll LJ, Lilja H, Isaacs JT. Prostate-specific antigen (PSA) protein does not affect growth of prostate cancer cells in vitro or prostate cancer xenografts in vivo. Prostate 2003;56:45-53.
29. Fortier AH, Holaday JW, Liang H, et al. Recombinant prostate specific antigen inhibits angiogenesis in vitro and in vivo. Prostate 2003;56:212-9.